These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 7009189
1. The abrogation of in vivo resistance to parental bone marrow transplantation and of in vitro natural cell-mediated cytotoxicity to the YAC lymphoma by in vivo growth of a transformed thymus-derived cell culture. Gardner FH, Gallagher MT, Datta SK, Trentin JJ. Exp Hematol; 1980 Sep; 8(8):1040-7. PubMed ID: 7009189 [Abstract] [Full Text] [Related]
2. Different sensitivities to hydrocortisone of natural killer cell activity and hybrid resistance to parental marrow grafts. Hochman PS, Cudkowicz G. J Immunol; 1977 Dec; 119(6):2013-5. PubMed ID: 334980 [Abstract] [Full Text] [Related]
3. Genetic resistance to bone marrow transplantation as a leukemia-lymphoma defense mechanism: correlation of "in vivo" lymphoma resistance and "in vitro" NK activity. Gallagher MT, Datta SK, Trentin JJ. Biomedicine; 1980 May; 33(3):73-5. PubMed ID: 7004513 [Abstract] [Full Text] [Related]
4. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice. Savary CA, Lotzová E. J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602 [Abstract] [Full Text] [Related]
5. Parallelism between the effect of cortisone acetate on hybrid resistance and natural killing. Lotzová E, Savary CA. Exp Hematol; 1981 Aug; 9(7):766-74. PubMed ID: 7032960 [Abstract] [Full Text] [Related]
6. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts. Zeis M, Uharek L, Glass B, Gaska T, Gassmann W, Mueller-Ruchholtz W. Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004 [Abstract] [Full Text] [Related]
7. Inhibition of hybrid resistance by 5-fluorouracil. Destruction of a Thy-1+ Lyt-1+2- spleen cell implicated in the expression of hybrid resistance. Kosmatopoulos K, Bravo-Cuellar A, Wachowiak J, Orbach-Arbouys S. Transplantation; 1987 Aug; 44(2):202-8. PubMed ID: 2888223 [Abstract] [Full Text] [Related]
8. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice. Takei F, Levy JG, Kilburn DG. J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160 [Abstract] [Full Text] [Related]
9. Depression of natural antitumor resistance of C57BL/6 mice by leukemogenic doses of radiation and restoration of resistance by transfer of bone marrow or spleen cells from normal, but not beige, syngeneic mice. Gorelik E, Herberman RB. J Natl Cancer Inst; 1982 Jul; 69(1):89-93. PubMed ID: 7047834 [Abstract] [Full Text] [Related]
11. Recognition and regulation of progenitor marrow elements by NK cells in the mouse. O'Brien T, Kendra J, Stephens H, Knight R, Barrett AJ. Immunology; 1983 Aug; 49(4):717-25. PubMed ID: 6192081 [Abstract] [Full Text] [Related]
12. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion. Suzuki Y, Adachi Y, Minamino K, Zhang Y, Iwasaki M, Nakano K, Koike Y, Ikehara S. Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931 [Abstract] [Full Text] [Related]
13. Kinetics and location of bone marrow cell graft rejection by irradiated mice. Sentman CL, Streilein R, Kumar V, Bennett M. Nat Immun Cell Growth Regul; 1988 Mar; 7(2):95-105. PubMed ID: 3045529 [Abstract] [Full Text] [Related]
14. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice. Davenport C, George T, Devora GA, Morris MA, Gordon BE, Kumar V, Bennett M. Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296 [Abstract] [Full Text] [Related]
15. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB. Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307 [Abstract] [Full Text] [Related]
16. Inhibition of natural killer cell-mediated lysis of tumor cells by normal and regenerating bone marrow. Miller SC, Galley D, Nguyen DM. Immunobiology; 1988 Apr; 177(1):82-90. PubMed ID: 3384448 [Abstract] [Full Text] [Related]
17. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system. Gjedde SB. Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250 [Abstract] [Full Text] [Related]
18. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens. Polisson RP, Shearer GM. J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920 [Abstract] [Full Text] [Related]
19. Genetic resistance to marrow transplantation as a leukemia defense mechanism. Gallagher MT, Lotzová E, Trentin JJ. Biomedicine; 1976 Feb 10; 25(1):1-3. PubMed ID: 786397 [Abstract] [Full Text] [Related]
20. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Apte RS, Mayhew E, Niederkorn JY. Invest Ophthalmol Vis Sci; 1997 May 10; 38(6):1277-82. PubMed ID: 9152248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]